(Q36409726)

14 August 2017

1 reference

title

Hematologic risk factors of vascular disease and their relation to dementia (English)

1 reference

14 August 2017

0 references

1 reference

1

Michelle M Mielke

1 reference

14 August 2017

Peter P Zandi

2

1 reference

14 August 2017

publication date

27 February 2006

1 reference

Dementia and Geriatric Cognitive Disorders

14 August 2017

published in

1 reference

14 August 2017

volume

21

1 reference

14 August 2017

issue

5-6

1 reference

14 August 2017

page(s)

335-352

1 reference

Alzheimer Disease in the US Population

14 August 2017

cites work

1 reference

Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review

21 January 2018

1 reference

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

21 January 2018

1 reference

Stroke and the risk of Alzheimer disease

21 January 2018

1 reference

Homocysteinemia due to folate deficiency

21 January 2018

1 reference

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

21 January 2018

1 reference

Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid — additional mechanisms in homocysteine induced endothelial damage?

21 January 2018

1 reference

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

Total serum homocysteine in senile dementia of Alzheimer type

21 January 2018

1 reference

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

21 January 2018

1 reference

Alzheimer's disease and total plasma aminothiols

21 January 2018

1 reference

Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease

21 January 2018

1 reference

Relation between plasma homocysteine and Alzheimer's disease

21 January 2018

1 reference

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol

21 January 2018

1 reference

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study

21 January 2018

1 reference

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation

21 January 2018

1 reference

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

21 January 2018

1 reference

Statins and the risk of dementia

21 January 2018

1 reference

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.

21 January 2018

1 reference

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

21 January 2018

1 reference

Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia

21 January 2018

1 reference

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

21 January 2018

1 reference

Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline

21 January 2018

1 reference

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

21 January 2018

1 reference

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections.

21 January 2018

1 reference

C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease.

21 January 2018

1 reference

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

21 January 2018

1 reference

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000091789

1 reference

14 August 2017

1 reference